Martin Babler - Jul 19, 2021 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
Director
Signature
/s/ Brian Piper, Attorney-in-Fact
Stock symbol
PRLD
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
4
Date filed
7/20/2021, 08:30 PM
Previous filing
May 13, 2021
Next filing
May 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLD Employee Stock Option (Right to Buy) Award $0 +36.4K $0.00 36.4K Jul 19, 2021 Common Stock 36.4K $31.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested as to 1/36 of the total shares monthly beginning on August 19, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.